Evaluate the Efficacy and Safety of the Prophylactic Use of PEG-rhG-CSF in Children With Hematological Malignancies
Clinical trial NCT04497701 · UNKNOWN
Trial details
- NCT number
- NCT04497701
- Sponsor
- CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-08-01
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.